Training program using animal models to improve tuberculosis research
Official title: Basic Science Core - Animal models
Funded at Texas Biomedical Research Institute · NIH-11031406 · Data updated 2026-11-12
This study is all about teaching people how to use animal models, like mice and monkeys, to better understand tuberculosis and develop new treatments and vaccines, while also making sure to follow ethical guidelines in research.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Biomedical Research Institute NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project start | March 10, 2022 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $126,967 |
| NIH project number | 5P30AI168439-04 |
| Project ID | NIH-11031406 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals interested in the development of new treatments for tuberculosis or those who may be at risk of TB infection.
✕Less likely to help
Patients who are not affected by tuberculosis or are not at risk for the disease may not receive any benefit from this research.
What this research studies
This research focuses on establishing a training program for participants to learn about tuberculosis (TB) using various animal models. It aims to translate laboratory findings into potential human applications by leveraging animal experimentation, particularly with mice and non-human primates. Participants will be educated on ethical considerations in animal research and will gain hands-on experience in designing experiments and testing new therapies and vaccines for TB. The program emphasizes the importance of the three R's: reduction, replacement, and refinement in animal research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies and vaccines for tuberculosis, ultimately benefiting patients with this disease.
How similar studies have gone: Previous research using animal models for tuberculosis has shown promise in understanding the disease and developing effective treatments, indicating that this approach is well-established.
Where this research is happening
-
Texas Biomedical Research Institute
San Antonio, United States Active
Researchers
- Principal investigator: Hall-Ursone, Shannan — Texas Biomedical Research Institute
- Study coordinator: Hall-Ursone, Shannan
Related research
Other NIH-funded projects on the same topics.
-
Targeting human HIV latency with super-enhancer RNA targets
A short, patient-friendly plan to explore how special RNA molecules in immune cells control HIV hiding in the body and how we might disrupt that to help control the virus.
-
Pathways to trigger protective MAIT cell responses against bacterial infections
A study to figure out which bacterial metabolite antigens activate MAIT cells through MR1 to defend against TB and tularemia.
-
IL-21 therapy to boost lung immunity in HIV/TB co-infection
A study tests an IL-21-based therapy added to HIV treatment to help the lungs control TB and reduce HIV persistence in people (or animal models that simulate them).
-
Focused ultrasound to open the blood-brain barrier and reduce HIV reservoirs in the brain
A new approach uses gentle ultrasound to temporarily open the brain’s protective barrier so HIV medicines can reach the brain and shrink hidden virus reservoirs in people living with HIV.
-
Macrophage biology and metabolism in TB infection
Researchers are studying human lung macrophages to understand how they regulate immune responses and support or limit tuberculosis infection, with the goal of improving treatments that help the body fight TB.
-
Understanding how genetics and immunity shape chikungunya brain disease
A research project uses genetically diverse mice to learn why chikungunya virus causes brain inflammation in some people and how immune responses contribute to this disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.